Parker Waichman, a national law firm, has filed multiple lawsuits where each Plaintiff alleged that he or she developed NAION after taking Novo Nordisk's Ozempic or Wegovy. The NAION/Ozempic lawsuits were recently featured in Newsday PORT WASHINGTON, N.Y., Aug. 20, 2025 /PRNewswire/ -- Parker Waichman has now filed multiple lawsuits in New Jersey state court on behalf of victims who were prescribed Ozempic or Wegovy and developed NAION, an irreversible eye condition that causes partial or compl

Funding positions KROMATID for accelerated growth in genomic analysis and gene editing technologies BOULDER, Colo., Aug. 20, 2025 /PRNewswire/ -- KROMATID, a leader in next-generation genomic structural analysis, today announced the successful close of its Series C funding round, raising a total of $8 million and surpassing its targeted capital goals. The most recent tranche of the round contributed $3.8 million. The round was led by BroadOak Capital Partners, with participation from both existi

American Cancer Society scientists highlight the importance of recognizing climate-related vulnerabilities and the need for drug supply chain transparency ATLANTA, Aug. 20, 2025 /PRNewswire/ -- In 2024, Hurricane Helene triggered a nationwide shortage of the country's intravenous (IV) fluids after damaging a facility in North Carolina. A similar IV fluid shortage was caused when Hurricane Maria hit Puerto Rico in 2017. In a new, nationwide study led by the American Cancer Society (ACS), scientis

BOSTON, Aug. 20, 2025 /PRNewswire/ -- Somite.ai, a company pioneering foundation models for human stem cells, today announced a strategic investment from AMD Ventures, following Somite's $47M Series A closing led by Khosla Ventures in May. The collaboration pairs Somite's capsule-based data generation platform with industry-leading AMD Instinct™ GPUs, significantly boosting compute power to accelerate training of Somite's foundation models. Continue Reading Somite is transforming cell therapy by

VIRGINIA BEACH, Va. and NIJMEGEN, Netherlands, Aug. 20, 2025 /PRNewswire/ -- In a transformative move to accelerate global access to life-restoring technologies, LifeNet Health, a world leader in regenerative medicine, has acquired HCM Medical, a Netherlands-based contract manufacturing organization (CMO) known for its pioneering biologics and tissue-processing capabilities. Continue Reading This strategic acquisition addresses a critical challenge in modern healthcare: ensuring timely, equitabl

HANGZHOU, China, Aug. 20, 2025 /PRNewswire/ -- Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX: 2190, hereinafter referred to as "Zylox-Tonbridge" or the "Company") today announced its interim results for the six months ended June 30, 2025. The Company achieved robust revenue growth of 31.7% year-over-year (YoY) to RMB 482 million, while net profit surged by 76.0% to exceed RMB 121 million, representing a net profit margin of 25.1%. In the first half of 2025, Zylox-Tonbridge maintained solid

Bagsværd, Denmark, 20 August 2025 – Novo Nordisk today announced new data showing the cardiovascular protective benefits of Wegovy ® and Ozempic ® will be presented at the European Society of Cardiology (ESC) Congress 2025 from 29 August to 1 September in Madrid, Spain. New data will also include perspectives on the role of inflammation in a condition called atherosclerotic cardiovascular disease (ASCVD). “For people living with diabetes and obesity, heart disease is one of the biggest threats t

Exclusive Human Milk Diet Significantly Impacts Developmental Milestones Years Later DUARTE, Calif., Aug. 20, 2025 /PRNewswire/ -- A groundbreaking study has revealed something remarkable about premature babies fed Prolacta Bioscience's Exclusive Human Milk Diet (EHMD): Despite being born earlier and weighing less — factors that typically predict greater developmental challenges — they still achieved better motor skills by age 3 than did larger preemies born later who received cow milk-based pr

With one easy blood test, Molecular You measures over 250 biomarkers, enabling more powerful and comprehensive insights for preventive and precision medicine PORTLAND, Ore. and VANCOUVER, BC, Aug. 20, 2025 /PRNewswire/ - Molecular You, a leader in molecular medicine and preventive health, today announced the closing of a $5 million USD Series A financing, led by Voloridge Health, LLC, with participation from Dynamic Leap and others. Continue Reading Molecular You measures over 250 biomarkers wi

SAN MARCOS, Calif., Aug. 20, 2025 /PRNewswire/ -- Grann Pharmaceuticals today announced a historic milestone in the development of transformative therapies for a rare and debilitating genetic disorder known as Rett Syndrome. The company's very first patient, Eleanor Elnekaveh, has successfully completed the experimental treatment regimen of RTT-1 (Eleanor), an mRNA lipid nanoparticle (LNP) protein replacement therapy. Grann was able to achieve this accomplishment from proof of concept to treatme